Peer Review History

Original SubmissionJuly 16, 2025
Decision Letter - Koichi Nishitsuka, Editor

Dear Dr. Sakanishi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 06 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Koichi Nishitsuka

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information

Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research .

3. We note that your Data Availability Statement is currently as follows:

“All relevant data are within the manuscript and its Supporting Information files.”

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

In addition to the reviewer’s comments, please address the following points in your revision:

1) The analysis of hemorrhage detection is based on only a few cases and should be considered preliminary. 

   Please acknowledge this explicitly in the Discussion as a limitation.  

2) Clinical outcomes such as surgical performance or postoperative vision were not assessed, which limits the study to proof-of-concept. 

   Please add a statement to this effect in the Discussion.  

3) Contrast measurements were performed by two evaluators, but inter-observer variability was not statistically assessed. 

   Please note this in the limitations section.

Reviewer #1:

Academic Editor:

1) The analysis of hemorrhage detection is based on only a few cases and should be considered preliminary. Please acknowledge this explicitly in the Discussion as a limitation.

2) Clinical outcomes such as surgical performance or postoperative vision were not assessed, which limits the study to proof-of-concept. Please add a statement to this effect in the Discussion.

3) Contrast measurements were performed by two evaluators, but inter-observer variability was not statistically assessed. Please note this in the limitations section.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

**********

Reviewer #1: This study is noteworthy as it explores an underexamined area of digitally assisted vitreoretinal surgery and provides a proof-of-concept that slight adjustments in saturation can enhance intraoperative safety by facilitating detection of retinal hemorrhage while preserving ILM contrast. I recommend the authors consider the following points:

1. Although not the primary aim of this study, the authors could suggest that future research evaluate actual surgical performance or clinical outcomes (e.g., ILM peeling time, ease of procedure, complication rates, postoperative vision).

2. The analysis of hemorrhage detection appears to rely on a limited number of cases; statistical robustness is therefore limited. Moreover, no quantitative data on the frequency or severity of hemorrhage across groups are provided.

3. The study is restricted to NGENUITY version 1.4, and the findings may not necessarily be generalizable to newer versions or other visualization platforms.

4. Contrast measurements were performed by only two evaluators, and potential inter-observer variability was not fully assessed.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Hamid Riazi-Esfahani

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

Revision 1

EDITOR COMMENTS

Editor Comment 1:

"The analysis of hemorrhage detection is based on only a few cases and should be considered preliminary. Please acknowledge this explicitly in the Discussion as a limitation."

Response: We agree with this important concern regarding the limited sample size for hemorrhage detection analysis. We have explicitly acknowledged this limitation and emphasized the preliminary nature of these findings in our Discussion section.

Changes made: Discussion section, Limitations paragraph - Added text:

"First, the analysis of hemorrhage detection is based on the small number of cases and should be considered preliminary."

Editor Comment 2:

"Clinical outcomes such as surgical performance or postoperative vision were not assessed, which limits the study to proof-of-concept. Please add a statement to this effect in the Discussion."

Response: We acknowledge that our study did not assess clinical outcomes and have explicitly stated that this work should be considered a proof-of-concept study demonstrating technical feasibility rather than clinical superiority.

Changes made: Discussion section, Limitations paragraph - Added text:

"Second, clinical outcomes such as actual surgical performance metrics (e.g., ILM peeling time, ease of procedure, complication rates) or postoperative visual outcomes were not assessed in this study. Therefore, this work should be considered a proof-of-concept study demonstrating the technical feasibility of contrast enhancement rather than evidence of clinical superiority."

Editor Comment 3:

"Contrast measurements were performed by two evaluators, but inter-observer variability was not statistically assessed. Please note this in the limitations section."

Response: We have acknowledged this limitation and noted that the lack of formal inter-observer variability assessment may affect the reproducibility of our contrast measurements.

Changes made: Discussion section, Limitations paragraph - Added text:

"Third, contrast measurements were performed by only two evaluators, and interobserver variability was not statistically assessed through formal reliability testing. This may affect the reproducibility of our contrast measurements."

REVIEWER #1 COMMENTS

Reviewer Comment 1:

"Although not the primary aim of this study, the authors could suggest that future research evaluate actual surgical performance or clinical outcomes (e.g., ILM peeling time, ease of procedure, complication rates, postoperative vision)."

Response: We appreciate this excellent suggestion and have incorporated specific directions for future research that include clinical outcome measures to validate our technical findings.

Changes made: Conclusion section - Added text:

"Further large multicenter cohort studies with clinical outcome measures are required to validate the present findings and establish the clinical benefits of these image enhancement techniques."

Reviewer Comment 2:

"The analysis of hemorrhage detection appears to rely on a limited number of cases; statistical robustness is therefore limited. Moreover, no quantitative data on the frequency or severity of hemorrhage across groups are provided."

Response: We acknowledge this limitation regarding the statistical robustness of our hemorrhage detection analysis. This concern has been addressed through the addition of explicit acknowledgment of the preliminary nature of these findings.

Changes made: Discussion section, Limitations paragraph - (Addressed through the same addition as Editor Comment 1 response, acknowledging the preliminary nature of hemorrhage detection analysis based on small sample size.)

Reviewer Comment 3:

"The study is restricted to NGENUITY version 1.4, and the findings may not necessarily be generalizable to newer versions or other visualization platforms."

Response: We fully agree with this important limitation regarding generalizability. We have acknowledged that our findings are specific to NGENUITY version 1.4 and have noted the need for validation across different systems and software versions.

Changes made: Discussion section, Limitations paragraph - Added text:

"Fifth, this study is limited to NGENUITY version 1.4, and the findings may not be generalizable to newer versions. Future studies should validate these findings across different systems and software versions. The NGENUITY ver1.5 is equipped with a mode that emphasizes blue even in the non-monochromatic mode, which will need to be considered in future studies."

Reviewer Comment 4:

"Contrast measurements were performed by only two evaluators, and potential inter-observer variability was not fully assessed."

Response: This important methodological limitation has been addressed in our revised manuscript through explicit acknowledgment in the limitations section.

Changes made: Discussion section, Limitations paragraph - (Addressed through the same addition as Editor Comment 3 response, noting the lack of statistical assessment of inter-observer variability.)

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Koichi Nishitsuka, Editor

Relationship between saturation and contrast during internal limiting membrane peeling in 3D digital vitreoretinal surgery: A retrospective study

PONE-D-25-33091R1

Dear Dr. Sakanishi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Koichi Nishitsuka

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Koichi Nishitsuka, Editor

PONE-D-25-33091R1

PLOS ONE

Dear Dr. Sakanishi,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Koichi Nishitsuka

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .